Journal article icon

Journal article

Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.

Abstract:

PURPOSE: The development of tumor-specific markers to select targeted therapies and to assess clinical outcome remains a significant area of unmet need. We evaluated the association of baseline circulating tumor cell (CTC) number with clinical characteristics and survival in patients with castrate metastatic disease considered for different hormonal and cytotoxic therapies. EXPERIMENTAL DESIGN: CTC were isolated by immunomagnetic capture from 7.5-mL samples of blood from 120 patients with pr...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
Clinical cancer research : an official journal of the American Association for Cancer Research
Volume:
13
Issue:
23
Pages:
7053-7058
Publication date:
2007-12-05
DOI:
EISSN:
1557-3265
ISSN:
1078-0432
URN:
uuid:f1050e02-827a-4c3b-ac23-d6d1252702b4
Source identifiers:
365940
Local pid:
pubs:365940

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP